about
Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents.Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade.5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair pathway.Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.Induction of apoptosis by 4-(3-(tert-butylamino)imidazo[1,2-α]pyridine-2-yl) benzoic acid in breast cancer cells via upregulation of PTEN.1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells.The contribution of heavy metals in cigarette smoke condensate to malignant transformation of breast epithelial cells and in vivo initiation of neoplasia through induction of a PI3K-AKT-NFκB cascade.Structural elaboration of a natural product: identification of 3,3'-diindolylmethane aminophosphonate and urea derivatives as potent anticancer agents.Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.Regulation of HuR structure and function by dihydrotanshinone-I.CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.Mutant KRAS Exosomes Influence the Metabolic State of the Colon Microenvironment.Quinacrine-mediated autophagy and apoptosis in colon cancer cells is through a p53- and p21-dependent mechanismIndenoindolone derivatives as topoisomerase II-inhibiting anticancer agents
P50
Q30839746-FDB6C866-E88E-4A74-A4C4-FE33F91DABB5Q35916388-1C50ADF9-5398-4478-824E-0CBE20482619Q36793966-557780E9-BF14-4A13-A37C-80C6948EF979Q37687521-1488AD35-31C9-468B-BD4A-2D0EA88F69A5Q37702210-1C83928D-B0E4-4B46-941F-3B2C79681E76Q39044354-B97612DA-1AD2-40A1-8959-B54920A4548AQ39060025-458A4495-E12C-4E75-B17A-8422304DF1A0Q39085291-26C3DE9E-4703-43D3-B7FC-C73592BAB180Q39104014-A7AF3B8B-8DD0-46B4-BCF0-FF5AA144A928Q39248886-378D5BD9-33D0-4877-AEE0-F60AA69ADB8DQ39547659-29CF190E-B887-4B4C-AF82-7E7F265FF50FQ47766837-70033F51-92C6-4687-8322-7D55A51A3B6DQ48820342-D097E49D-6093-480C-BB63-3350E966EB6EQ55014528-6500154A-44B4-46A3-A4F5-7FBB351DDC11Q85567232-53B59B0E-2E11-47F2-B7B4-15BCE2F2EA3AQ85900479-EFA1CCE3-7039-4A81-8992-6765AE987A04
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ranjan Preet
@ast
Ranjan Preet
@en
Ranjan Preet
@es
Ranjan Preet
@nl
Ranjan Preet
@sl
type
label
Ranjan Preet
@ast
Ranjan Preet
@en
Ranjan Preet
@es
Ranjan Preet
@nl
Ranjan Preet
@sl
prefLabel
Ranjan Preet
@ast
Ranjan Preet
@en
Ranjan Preet
@es
Ranjan Preet
@nl
Ranjan Preet
@sl
P106
P1153
43762234700
P31
P496
0000-0001-6117-2701